ArticleBritish journal of cancer1999

Synergistic inhibition of prostate cancer cell lines by a 19-nor hexafluoride vitamin D3 analogue and anti-activator protein 1 retinoid.

M J Campbell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.